Resistance to insulin-stimulated glucose uptake is associated with sev
eral cardiovascular disease risk factors, including hypertension, dysl
ipidemia, and alterations of the blood clotting cascade that accentuat
e thrombosis. This constellation of risk factors may be recognized at
young ages and is at least in part heritable. Recognition of this synd
rome dictates that preventive and therapeutic strategies should addres
s overall cardiovascular disease risk. In patients with hypertension o
r diabetes, additional clinical trials are required to identify those
interventions that will most effectively reduce not only overall risk
but also definitive cardiovascular disease endpoints.